NZ239061A - 3-(tetrahydrofuranyl)-ceph-3-em-4-carboxylic acid derivatives, 1-dethia-1-carba (and 1-oxa) analogues; preparatory processes and pharmaceutical compositions - Google Patents

3-(tetrahydrofuranyl)-ceph-3-em-4-carboxylic acid derivatives, 1-dethia-1-carba (and 1-oxa) analogues; preparatory processes and pharmaceutical compositions

Info

Publication number
NZ239061A
NZ239061A NZ239061A NZ23906191A NZ239061A NZ 239061 A NZ239061 A NZ 239061A NZ 239061 A NZ239061 A NZ 239061A NZ 23906191 A NZ23906191 A NZ 23906191A NZ 239061 A NZ239061 A NZ 239061A
Authority
NZ
New Zealand
Prior art keywords
carboxylate
ceph
tetrahydrofuran
aminothiazol
group
Prior art date
Application number
NZ239061A
Other languages
English (en)
Inventor
John Hargreaves Bateson
George Burton
Stephen Christopher Marti Fell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of NZ239061A publication Critical patent/NZ239061A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ239061A 1990-07-24 1991-07-22 3-(tetrahydrofuranyl)-ceph-3-em-4-carboxylic acid derivatives, 1-dethia-1-carba (and 1-oxa) analogues; preparatory processes and pharmaceutical compositions NZ239061A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds

Publications (1)

Publication Number Publication Date
NZ239061A true NZ239061A (en) 1993-11-25

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ239061A NZ239061A (en) 1990-07-24 1991-07-22 3-(tetrahydrofuranyl)-ceph-3-em-4-carboxylic acid derivatives, 1-dethia-1-carba (and 1-oxa) analogues; preparatory processes and pharmaceutical compositions

Country Status (26)

Country Link
EP (2) EP0540606A1 (cs)
JP (2) JP2851428B2 (cs)
KR (1) KR100189075B1 (cs)
CN (2) CN1061046C (cs)
AP (1) AP832A (cs)
AT (1) ATE185567T1 (cs)
AU (1) AU648329B2 (cs)
CA (2) CA2359744C (cs)
CZ (1) CZ6493A3 (cs)
DE (2) DE69131714T2 (cs)
DK (1) DK0540609T3 (cs)
ES (1) ES2137162T3 (cs)
FI (1) FI930270A7 (cs)
GR (1) GR3031711T3 (cs)
HU (1) HUT63628A (cs)
IE (1) IE912569A1 (cs)
IL (1) IL98909A0 (cs)
LU (1) LU91290I2 (cs)
MX (1) MX9100317A (cs)
MY (1) MY106399A (cs)
NL (1) NL300249I1 (cs)
NO (1) NO930226L (cs)
NZ (1) NZ239061A (cs)
PT (1) PT98426A (cs)
WO (2) WO1992001696A1 (cs)
YU (1) YU129691A (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
AU3264393A (en) * 1992-01-22 1993-09-01 Smithkline Beecham Plc 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
AU4398297A (en) * 1996-10-02 1998-04-24 Daiichi Pharmaceutical Co., Ltd. Method for esterifying carboxylic compounds
FR2776292B1 (fr) 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
BR0115870A (pt) * 2000-12-04 2004-02-03 Pfizer Prod Inc Processos de acoplamento e intermediários úteis para preparação de cefalosporinas
ES2257471T3 (es) * 2000-12-04 2006-08-01 Pfizer Products Inc. Procedimiento y derivados esteres utiles para la preparacion de cefalosporinas.
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
SG10201610936RA (en) 2011-12-22 2017-02-27 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013174962A1 (en) 2012-05-25 2013-11-28 Janssen R&D Ireland Uracyl spirooxetane nucleosides
CN110684067A (zh) 2012-12-21 2020-01-14 艾丽奥斯生物制药有限公司 取代的核苷和核苷酸
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
TW202023625A (zh) 2018-08-23 2020-07-01 美商西雅圖遺傳學公司 抗tigit抗體
DK4069691T3 (da) 2019-12-06 2024-10-28 Vertex Pharma Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
EP4106876B1 (en) 2020-02-18 2025-09-17 Gilead Sciences, Inc. Antiviral compounds
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
TWI874791B (zh) 2020-02-18 2025-03-01 美商基利科學股份有限公司 抗病毒化合物
CN111620893B (zh) * 2020-06-08 2021-12-14 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用
KR102923359B1 (ko) 2021-04-16 2026-02-05 길리애드 사이언시즈, 인코포레이티드 아미드를 사용한 카르바뉴클레오시드를 제조하는 방법
MA64853B1 (fr) 2021-06-04 2025-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hétéro)aryl) tétrahydrofuran carboxamides utilisés en tant que modulateurs de canaux sodiques
EP4387977A1 (en) 2021-08-18 2024-06-26 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
CN121181574B (zh) * 2025-11-24 2026-02-24 重庆汉佩生物科技有限公司 一种头孢维星衍生物和应用以及制备方法
CN121181573B (zh) * 2025-11-24 2026-02-27 重庆汉佩生物科技有限公司 一种含c-3位四氢呋喃头孢菌素衍生物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
NL7305936A (cs) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ATE171705T1 (de) * 1989-03-30 1998-10-15 Pfizer Cephalosporine und ihre homologen, verfahren zu ihrer herstellung und pharmazeutische präparate

Also Published As

Publication number Publication date
EP0540606A1 (en) 1993-05-12
MX9100317A (es) 1992-02-28
HUT63628A (en) 1993-09-28
DK0540609T3 (da) 1999-12-27
CA2087967A1 (en) 1992-01-25
JPH05509089A (ja) 1993-12-16
FI930270L (fi) 1993-03-22
YU129691A (sh) 1994-01-20
DE122006000065I1 (de) 2007-03-01
NO930226L (no) 1993-03-23
ES2137162T3 (es) 1999-12-16
JP2851428B2 (ja) 1999-01-27
IE912569A1 (en) 1992-01-29
CN1061046C (zh) 2001-01-24
CA2359744C (en) 2007-02-13
EP0540609B1 (en) 1999-10-13
FI930270A7 (fi) 1993-03-22
KR100189075B1 (ko) 1999-06-01
ATE185567T1 (de) 1999-10-15
CA2087967C (en) 2002-09-10
DE122006000065I2 (de) 2007-09-13
MY106399A (en) 1995-05-30
AU8222491A (en) 1992-02-18
AP832A (en) 2000-05-03
WO1992001695A1 (en) 1992-02-06
EP0540609A1 (en) 1993-05-12
CA2359744A1 (en) 1992-02-06
CZ6493A3 (en) 1994-04-13
PT98426A (pt) 1992-05-29
CN1111410C (zh) 2003-06-18
LU91290I2 (fr) 2007-01-22
IL98909A0 (en) 1992-07-15
NO930226D0 (no) 1993-01-22
CN1223859A (zh) 1999-07-28
AU648329B2 (en) 1994-04-21
WO1992001696A1 (en) 1992-02-06
DE69131714T2 (de) 2000-02-24
FI930270A0 (fi) 1993-01-22
HU9300177D0 (en) 1993-04-28
GR3031711T3 (en) 2000-02-29
KR930701456A (ko) 1993-06-11
CN1060469A (zh) 1992-04-22
DE69131714D1 (de) 1999-11-18
JPH05509305A (ja) 1993-12-22
NL300249I2 (en) 2007-02-01
AP9100305A0 (en) 1991-07-31
NL300249I1 (nl) 2007-02-01

Similar Documents

Publication Publication Date Title
NZ239061A (en) 3-(tetrahydrofuranyl)-ceph-3-em-4-carboxylic acid derivatives, 1-dethia-1-carba (and 1-oxa) analogues; preparatory processes and pharmaceutical compositions
US5246926A (en) Cephalosporin derivatives
US5064649A (en) Cephalosporin derivatives
US6077952A (en) Cephaloporins and homologues
US6020329A (en) Cephaloporins and homologues, preparations and pharmaceutical compositions
US5578591A (en) 2-isocephem and oxacephem derivatives, and use as antibacterial agents
US5716948A (en) 3-substituted carbacephems
US5158946A (en) Cephalosporin derivatives and pharmaceutical compositions
EP0287734A1 (en) 2-Beta-substituted methyl-penam derivatives
JP2851429B2 (ja) セファロスポリン誘導体およびそれらの同族体
US6080855A (en) 2-isocephem and oxacephem derivatives and use as antibacterial agents
US5602117A (en) Cephalosporin compounds
US5635501A (en) Alphalosporins and 1-carba-1-dethia cephalosporins
EP0354757A2 (en) Cephalosporins and homologous compounds, process for their preparation and pharmaceutical compositions containing them
AP199A (en) Novel B-Lactam and a novel class cephalosporins.
US5578592A (en) Cephalosporin derivatives
US5665717A (en) Carbacephalosporin compound, their preparation and use
EP0651755A1 (en) Cephalosporins and 1-carba-1-dethia cephalosporins
EP0389178A2 (en) Acrylamido-penicillanic-acid derivatives

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired